Delaware Business Blog

The Cutting Edge: Biotechnology in New Castle County

Digital Delaware- Bringing Technology Leaders Together

Digital Delaware May Educational Event

    Ground breaking research, revolutionary manufacturing technologies and multi-disciplinary processes are being developed right here in New Castle County, Delaware. The Cutting Edge series features new technology-based economic development opportunities in New Castle County.

      WHEN: Wednesday, May 17 2006

      WHERE:
      AstraZeneca
      1800 Concord Pike Wilmington, DE

      TIME: 5:00 p.m. – 7:00 p.m.

      COST: $50.00 for Digital Delaware and NCCCC members or for $60.00 non-members
      You must pre-register to attend

    Want more information?
    Contact Dale Ervin at (302) 294-2058.

    Or click here to view the invitation and to register online.

    3 thoughts on “The Cutting Edge: Biotechnology in New Castle County

    1. Alan

      “”Ground breaking research, revolutionary manufacturing technologies and multi-disciplinary processes are being developed right here in New Castle County, Delaware. The Cutting Edge series features new technology-based economic development opportunities in New Castle County.

      Personally, I think the State does not understand tech very well. I have attended some of the planning meetings for this effort and was not particularly impressed. Russ, have you attended any tech outreach meetings yet?

    2. Alan

      Speaking of which, from today’s News Journal Online:
      AstraZeneca Plc. plans to spend $100 million in China over the next three years to develop drugs for the Chinese market, the company said.

      By the end of 2009, the company expects to open the AstraZeneca Innovation Centre China, whose initial focus will be on developing cancer drugs

      AstraZeneca, whose U.S. operation in based in Fairfax, already has a strong presence in China, where it employs 2,200 people. The company’s China headquarters is in Shanghai, it maintains branch offices in more than 20 cities and operates a manufacturing plant in Wuxi in Jiangsu province.

      In addition, AstraZeneca has a development partnership with Chinese company Wuxi Pharmatech, and is collaborating with China’s Shanghai Jiao Tong University on schizophrenia research.

    3. Russell Rozanski Post author

      Hi Alan,

      Thanks for the feedback. It’s good to hear comments from someone who has actually attended some of the events posted about on this blog. I haven’t been to any of the technology-based economic development events; though we are all dependent upon it in one way or another, technology isn’t my strongest area of knowledge and interest.
      : )

      One thing I can defiantly agree with you on is that generally government at any level is pretty slow to react and understand core issues surrounding many businesses. That is of course unless you have a lobbying campaign or a former CEO holding a political office somewhere…

      Money talks (unfortunately) when it comes to politics.

      I did attend a Digital Delaware Event in the past that I enjoyed.
      Did you not like the DD experience or was it really the State’s involvement that left you unimpressed?

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>